LSU Health New Orleans

Departments & Centers | Contact | Donate

Administration Basic Sciences Clinical Sciences Centers of Excellence

        family        

2014 4:01:03 PM 

 

 


 
Contact Us

Diptasri Mandal, PhD:

Principal Investigator

(504) 568-6156
dmanda@lsuhsc.edu      


Angelle Bencaz, MSPH:
(504) 568-2216
abenca@lsuhsc.edu
 

Jessica Chambliss, MS, CRC:
(504) 568-7027
jcham5@lsuhsc.edu

Toll-Free: 1-888-720-2257
LungCaStudy@lsuhsc.edu      

 

Click here to email us your contact information

 

 

Lung Cancer Study Pamphlet

Lung Cancer Study Flyer

Study Newsletters

Lung Cancer Study Newsletters:                                                                                                                                                                                                                           2012
2013
2014

Funding

Funds to support this project have been obtained from:

National Heart, Lung, and Blood Institute (NHLBI)

National Institutes of Health (NIH)

GELCC

The Lung Cancer Study is part of the Genetic Epidemiology of Lung Cancer Consortium (GELCC):

Hospital Collaborators

Our Study's Local Network of Collaborators:

 

 

Related Articles and Publications

LUNG CANCER RESEARCH STUDY: 

"Genetic Epidemiology of Lung Cancer"


What is the Lung Cancer Study?

  • The Lung Cancer Research Study at LSU Health Sciences Center in New Orleans first began on October 1st, 1996. The study has been on-going ever since.
  • The Lung Cancer Study aims to find the gene(s) that may cause lung cancer.
  • The study will help scientists understand how the gene(s) work with environmental factors (such as smoking and other exposures) in causing lung cancer.

 

What information does the Lung Cancer Study collect from participating individuals?

  • We collect demographic, medical, and smoking history information by mail and/or phone.
  • With the kits we provide, a one-time only blood sample and/or saliva sample at your convenience.
  • Pathology reports and medical records if diagnosed with lung cancer upon authorization of the patient or next-of-kin will also be collected when beneficial.

 

Is the information collected for this study protected?

  • Yes, we are fully compliant with HIPAA (Health Insurance Portability & Accountability Act) and have received approval from the IRB (Institutional Review Board).
  • All of the information is collected, coded, and stored in a confidential manner. 
  • No identifiable information is shared with anyone outside this study.
  • Everything you provide will remain strictly confidential. Your privacy is important to us.

 

Who can participate in this study?

  • Anyone diagnosed with lung cancer is encouraged to contact us.
  • Family members may have the opportunity to participate.
  • Any current or former smoker over 60 years of age that are not diagnosed with lung cancer and do not have a family history of lung cancer can participate as a "control."
  • We also welcome participation from spouses of enrolled lung cancer cases as (married-in) controls if they do not have a family history of lung cancer.
  • You can participate no matter where you live. Participants do not need to come to LSU Health Sciences Center for enrollment. All information can be provided remotely, all-expenses-paid.

 

Is there any cost to participate?

  • No, there is no cost to participate in the study. 
  • All study-related materials and kits will be provided to you free of charge.

 

Why should people participate?

  • Lung cancer is the second most common form of cancer diagnosed among men and women with the leading cause of cancer deaths in the United States. 
  • Some people may carry a gene(s) that increases their risk of developing lung cancer when exposed to certain environmental agents.
  • The study investigators are identifying and learning about people susceptible to lung cancer in order to find information that can lead to cancer prevention in the future. Identifying cancer susceptibility gene(s) in individuals and/or families can play a major role in preventing the disease before it occurs.
  • This study also encourages participants to gain further knowledge of their family's health history. Collecting your family history can be an important tool used in assessing your risks for certain inherited diseases.
  • Participation of more families will give us better opportunities of finding the familial lung cancer gene(s).

 

How will participating help in the fight against lung cancer?

  • Participants will not benefit directly from this study, but they will help us understand more about the genetic causes of lung cancer.
  • Individuals taking part in this study today will help future generations. Participation may result in a future benefit to the patient or to other relatives in finding the gene(s) that increase the risk for lung cancer in some families.
  • In the long run, participation may contribute to the development of better lung cancer diagnoses, individualized treatments, and preventions.

                                       Picture1